PARAGON-HF: Lessons Learned and Perspectives

Saraiva, José Francisco Kerr; Oliveira, Isadora de

Saraiva, José Francisco Kerr; Oliveira, Isadora de.

Saraiva, José Francisco Kerr; PUC-Campinas. Campinas. BR
Oliveira, Isadora de; Novartis Brasil - Medical Affairs. São Paulo. BR

Int. j. cardiovasc. sci. (Impr.) ; 33(3): 278-281, May-June 2020.

Article in English | LILACS | ID: biblio-1134365

Subject(s)

Humans; Angiotensin II Type 1 Receptor Blockers/therapeutic use; Valsartan/therapeutic use; Heart Failure/physiopathology; Echocardiography/methods; Heart Disease Risk Factors; Heart Failure/diagnosis; Heart Failure/drug therapy

Dysfunction Left Ventricular/abnormalities; Echocardiography/methods; Heart Failure/physiopathology; Indicators of Morbidity and Mortality; Neprilysin/therapeutic use; Risk Factors; Valsartan/therapeutic use

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Angiotensin II Type 1 Receptor Blockers / Valsartan / Heart Failure Type of study: Diagnostic study / Etiology study / Risk factors Limits: Humans Language: English Journal: Int. j. cardiovasc. sci. (Impr.) Journal subject: Cardiology Year: 2020 Type: Article Affiliation country: Brazil Institution/Affiliation country: Novartis Brasil - Medical Affairs/BR / PUC-Campinas/BR

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google